10x Genomics Inc (TXG)

Form 4 - Statement of changes in beneficial ownership of securities

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell...

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group PR Newswire PLEASANTON...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics Reports First Quarter 2026 Financial Results PR Newswire PLEASANTON, Calif., May 7, 2026...

Form 8-K - Current report

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors